Description:

CALGB 40503 ELIGIBILITY CHECKLIST NCT00601900 Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=2DB1C326-547F-15B1-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=2DB1C326-547F-15B1-E044-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/9/15
  3. 6/18/15
Uploaded on:

June 18, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

CALGB 40503 ELIGIBILITY CHECKLIST NCT00601900

INSTRUCTIONS: Complete all information on this form. Submit within one week of registration along with the On-Study Form.

Header
Patient demographics
Eligibility Criteria
Eligibility criteria
Footer Module

Similar models